Dr. Diana E. Lake, MD

Dr. Lake practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Lake's NPI, 1346211380, was assigned on January 29, 2006. Dr. Lake graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1972. Dr. Lake holds New York license 126566.

Dr. Lake's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Lake's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Lake to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Lake's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lake practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lake's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Lake is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lake's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists breast cancer among the conditions Dr. Lake treats.

CMS data shows 474 Medicare services from Dr. Lake across 4 procedure codes in 2024, all of them office visits, for 196 Medicare patients. Medicare paid $42,833 for them. Every service was in an office.

CMS counts 196 Medicare patients who saw Dr. Lake in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have cancer, and 71% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lake's median patient age at 69, with 97% women.

In 2024, Dr. Lake wrote 769 Medicare Part D claims for 203 patients. 85% of them were for generic drugs. CMS names the drug for 643 of them, across 9 drugs with 11 or more claims each, at $1,220,771 in total drug cost. In 2023, CMS named 625 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Lake for performance year 2024, reported as part of a group. Dr. Lake accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lake as offering telehealth.

Dmand AI links 32 papers to Dr. Lake, published from 2007 to 2024. 2008 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal, Humanized. Dr. Lake has published most often in Breast Cancer Res Treat. Dr. Lake's most frequent co-authors are Clifford A. Hudis, MD, Larry Norton, MD and Gabriella M. D'Andrea, MD.

Dmand AI links Dr. Lake to 3 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Neoplasms, Male and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 2 general payments to Dr. Lake from 2 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 91% of the total. Pfizer Inc. paid the most, $125.

Dmand AI lists 2 awards for Dr. Lake, most recently ACP Fellow in 1997.

Dr. Lake graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1972. Dr. Lake is a member of ACP.

Dr. Lake is in network with 10 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.